EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

18 F-Fluorodeoxyglucose Uptake in PDGFRA -Mutant Gastrointestinal Stromal Tumors

Maria Concetta Nigro, Andrea Marchetti, Elena Rosa Fumagalli, Ida De Luca, Alexia Francesca Bertuzzi, Maria Susanna Grimaudo, Giovanni Grignani, Lorenzo D'Ambrosio, Alessandra Merlini, Giuseppe Badalamenti, Lorena Incorvaia, Alessandra Dimino und 8 weitere

JAMA Network Open · 24.01.2025 · 8 (1) · e2456058

DOI: 10.1001/jamanetworkopen.2024.56058 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Network Open, online erschienen am 24.01.2025. Verfasst von Maria Concetta Nigro und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Fluorodeoxyglucose F18, Receptor, Platelet-Derived Growth Factor alpha, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The D842V platelet-derived growth factor receptor α ( PDGFRA ) mutation identifies a molecular subgroup of gastrointestinal stromal tumors (GISTs), primarily resistant to standard tyrosine kinase inhibitors and with an overall more indolent behavior. Although functional imaging with 18 F-fluorodeoxyglucose–labeled positron emission tomography ([ 18 F]FDG-PET) plays a proven role in GISTs, especially in early assessment of tumor response, less is known about [ 18 F]FDG uptake according to the GIST molecular subtypes.

Objective

To evaluate the degree of [ 18 F]FDG uptake in PDGFRA -mutant GISTs and better define the role of functional imaging in this rare and peculiar subset of GISTs. Design, Setting, and Participants This multi-institutional retrospective cohort study involving 7 GIST reference centers in Italy included patients with PDGFRA -mutant GIST who underwent [ 18 F]FDG-PET from January 1, 2000, to December 31, 2023. Data on the maximum standardized uptake value (SUVmax) of primary tumor or metastatic disease were collected. Exposure PDGFRA -mutant GIST and [ 18 F]FDG-PET. Main Outcome and Measure The primary outcome was the degree of [ 18 F]FDG uptake of PDGFRA -mutant GISTs, with a focus on the D842V-mutant subgroup. Secondary objectives were to assess the association between the degree of [ 18 F]FDG uptake and main clinicopathologic features.

Results

A total of 71 patients with PDGFRA -mutant GISTs were included in the analysis: 37 (52.1%) in the D842V subgroup (group A) and 34 (47.9%) in the non-D842V subgroup (group B). Additionally, 70 patients with KIT exon 11–mutant GIST served as a control group (group C). For all 141 participants, the median age at diagnosis was 59 (range, 26-89) years, and 81 patients (57.4%) were male. Overall, the median SUVmax was 4.4 (IQR, 0-10.1), while the median SUVmax for group A was 0 (IQR, 0-3.2); for group B, 3.6 (IQR, 0-5.1); and for group C, 10.1 (IQR, 5.1-13.9). The median SUVmax of PDGFRA -mutant GISTs was significantly lower than the median value of KIT exon 11–mutant GISTs (0 [IQR, 0-4.3] vs 10.1 [IQR, 5.1-14.0]; P < .001). Median [ 18 F]FDG uptake was significantly lower in the D842V subgroup compared with the non-D842V subgroup (0 [IQR, 0-3.2] vs 3.6 [IQR, 0-5.1]; P = .02). Moreover, the triad of gastric primary tumor, tumor size greater than 10 cm, and SUVmax of 5.75 or less was associated with identification of PDGFRA -mutant GISTs. Conclusions and Relevance In this cohort study of patients with PDGFRA -mutant GISTs, the D842V-mutant GISTs were associated with an overall lower [ 18 F]FDG uptake compared with other GIST subgroups. Therefore, the role of functional imaging with [ 18 F]FDG-PET in this subset of GISTs may be limited and should be further explored for its potential prognostic and predictive value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsFluorodeoxyglucose F18Receptor, Platelet-Derived Growth Factor alphaGastrointestinal NeoplasmsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesMutationAdultPositron-Emission TomographyRadiopharmaceuticalsAged, 80 and overItaly

Substanzen

Fluorodeoxyglucose F18Receptor, Platelet-Derived Growth Factor alphaRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Medical Oncology Unit 2, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori, Milano, Italy.
  • Department of Medical Oncology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy.
  • Department of Medical Oncology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Candiolo Cancer Institute, Fondazione del Piemonte-IRCCS, Candiolo (Turin), Turin, Italy.
  • Department of Medical Oncology, University of Turin, Turin, Italy.

Zitieren

APA

Nigro, M. C., Marchetti, A., Fumagalli, E. R., De Luca, I., Bertuzzi, A. F., Grimaudo, M. S., Grignani, G., D'Ambrosio, L., Merlini, A., Badalamenti, G., Incorvaia, L., Dimino, A., Gasperoni, S., Vincenzi, B., Fanti, S., Di Federico, A., Campana, D., Pantaleo, M. A., Nannini, M., & Tumori Rari Bologna (2025). 18 F-Fluorodeoxyglucose Uptake in PDGFRA -Mutant Gastrointestinal Stromal Tumors. JAMA Network Open, 8(1), e2456058. https://doi.org/10.1001/jamanetworkopen.2024.56058

Vancouver

Nigro MC, Marchetti A, Fumagalli ER, De Luca I, Bertuzzi AF, Grimaudo MS, et al. 18 F-Fluorodeoxyglucose Uptake in PDGFRA -Mutant Gastrointestinal Stromal Tumors. JAMA Network Open. 2025;8(1):e2456058. doi:10.1001/jamanetworkopen.2024.56058

BibTeX
@article{Nigro2025,
  author = {Nigro, Maria Concetta and Marchetti, Andrea and Fumagalli, Elena Rosa and De Luca, Ida and Bertuzzi, Alexia Francesca and Grimaudo, Maria Susanna and Grignani, Giovanni and D'Ambrosio, Lorenzo and Merlini, Alessandra and Badalamenti, Giuseppe and Incorvaia, Lorena and Dimino, Alessandra and Gasperoni, Silvia and Vincenzi, Bruno and Fanti, Stefano and Di Federico, Alessandro and Campana, Davide and Pantaleo, Maria Abbondanza and Nannini, Margherita and Tumori Rari Bologna, Tumori Rari Bologna},
  title = {18 F-Fluorodeoxyglucose Uptake in PDGFRA -Mutant Gastrointestinal Stromal Tumors},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {1},
  pages = {e2456058},
  doi = {10.1001/jamanetworkopen.2024.56058}
}
Kostenlos starten →